John Hussman's MD Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 63,000 shares of Pediatrix Medical Group, Inc. (MD) worth $1.35 M, representing 0.29% of the portfolio. First purchased in 2015-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, John Hussman has maintained a strategic position in MD, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 126,000 shares. Largest reduction occurred in Q4 2025, reducing 168,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Pediatrix Medical Group (MD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pediatrix Medical Group (MD) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +63,000 | New Buy | 63,000 | $21.39 |
| Q4 2025 | -168,000 | Sold Out | 0 | $0.00 |
| Q3 2025 | -42,000 | Reduce 20.00% | 168,000 | $16.75 |
| Q2 2025 | +126,000 | Add 150.00% | 210,000 | $14.35 |
| Q1 2025 | +84,000 | New Buy | 84,000 | $14.49 |
| Q1 2022 | -26,000 | Sold Out | 0 | $0.00 |
| Q4 2021 | +26,000 | New Buy | 26,000 | $27.19 |
| Q2 2021 | -7,200 | Sold Out | 0 | $0.00 |
| Q1 2021 | +7,200 | New Buy | 7,200 | $25.42 |
| Q1 2019 | -1,700 | Sold Out | 0 | $0.00 |
| Q4 2018 | +1,700 | New Buy | 1,700 | $32.94 |
| Q4 2015 | -30,000 | Sold Out | 0 | $0.00 |
| Q3 2015 | +30,000 | New Buy | 30,000 | $76.80 |
John Hussman's Pediatrix Medical Group Investment FAQs
John Hussman first purchased Pediatrix Medical Group, Inc. (MD) in Q3 2015, acquiring 30,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Pediatrix Medical Group, Inc. (MD) for 13 quarters since Q3 2015.
John Hussman's largest addition to Pediatrix Medical Group, Inc. (MD) was in Q2 2025, adding 210,000 shares worth $3.01 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 63,000 shares of Pediatrix Medical Group, Inc. (MD), valued at approximately $1.35 M.
As of the Q1 2026 filing, Pediatrix Medical Group, Inc. (MD) represents approximately 0.29% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Pediatrix Medical Group, Inc. (MD) was 210,000 shares, as reported at the end of Q2 2025.